ACSL4: a double-edged sword target in multiple myeloma, promotes cell proliferation and sensitizes cell to ferroptosis
Authors:
- 1 March 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in Carcinogenesis
- Vol. 44 (3) , 242-251
Abstract
Overactive fatty acid metabolism is usually found in hematological malignancies including multiple myeloma (MM), but the underlying mechanisms remain unclear. Here, we reveal that acyl-CoA synthetase long-chain family member 4 (ACSL4) is abnormally overexpressed in MM cell lines and MM patients compared to healthy donors. Knockdown of ACSL4 inhibited MM cell proliferation and reduced fatty acid levels possibly by regulating lipid metabolism genes including c-Myc and sterol regulatory element binding proteins (SREBPs). As a propellent in ferroptosis, ACSL4 also determines the sensitivity of MM cells to ferroptosis inducer RSL3. Knockdown of ACSL4 rendered MM cells resistance to ferroptosis. Our findings suggest that ACSL4 is a double-edged sword target in MM. Based on the high expression of ACSL4, ferroptosis induction represents a promising therapeutic strategy for MM.Keywords
Funding Information
- National Key R&D Program of China (2019YFC1316204)
- National Natural Science Foundation of China (81974007 and No. 82270214)
This publication has 60 references indexed in Scilit:
- Arachidonic acid downregulates acyl-CoA synthetase 4 expression by promoting its ubiquitination and proteasomal degradationJournal of Lipid Research, 2014
- Cellular Fatty Acid Metabolism and CancerCell Metabolism, 2013
- Characterization of the mouse promoter region of the acyl-CoA synthetase 4 gene: Role of Sp1 and CREBMolecular and Cellular Endocrinology, 2013
- Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell DeathCell, 2012
- Tyrosine phosphatase SHP2 regulates the expression of acyl-CoA synthetase ACSL4Journal of Lipid Research, 2011
- Genome-wide Characterization of miR-34a Induced Changes in Protein and mRNA Expression by a Combined Pulsed SILAC and Microarray AnalysisMolecular & Cellular Proteomics, 2011
- A mechanistic rationale for MEK inhibitor therapy in myeloma based on blockade of MAF oncogene expressionBlood, 2011
- Mammalian Long-Chain Acyl-CoA SynthetasesExperimental Biology and Medicine, 2008
- Rosiglitazone Inhibits Acyl-CoA Synthetase Activity and Fatty Acid Partitioning to Diacylglycerol and Triacylglycerol via a Peroxisome Proliferator–Activated Receptor-γ–Independent Mechanism in Human Arterial Smooth Muscle Cells and MacrophagesDiabetes, 2007
- Oncomine 3.0: Genes, Pathways, and Networks in a Collection of 18,000 Cancer Gene Expression ProfilesNeoplasia, 2007